Current treatments for stroke, for example, are limited by our lack of understanding of how neuronal injury develops within the brain and why neurons survive or die after a stroke. This is also why we still don't have a cure for most fatal and progressive neurodegenerative disorders.
The Marie Curie Industry-Academia Partnership and Pathways programme, OXY-SENSE is developing a new technology to monitor the level of oxygen in cells.
The probe has still to complete the in vivo testing phase, but if this is successful the OXY-SENSE project will have taken an important step towards our understanding how and why cells die – and therefore to the development of more effective treatments for a number of medical conditions.
In bringing together academia and industry in a close working partnership, accelerating the technology transfer process and the commercial exploitation of research findings, the project will have also achieved another of its important goals, benefiting not just patients, but European competitiveness as a whole.
More on OXY-SENSE project: http://cordis.europa.eu/projects/rcn/91150_en.html